Colorectal Adenocarcinoma
Colorectal adenocarcinoma is a type of cancer that begins in the cells of the colon or rectum, often leading to symptoms such as changes in bowel habits, abdominal pain, and unexplained weight loss.
We are studying short-course targeted treatments for patients with resectable colorectal cancer to see if they improve treatment response and quality of life. This trial aims to understand the safety and effectiveness of these treatments before surgery.
Health conditions and diseases that the clinical trial is designed to study and treat.
Colorectal adenocarcinoma is a type of cancer that begins in the cells of the colon or rectum, often leading to symptoms such as changes in bowel habits, abdominal pain, and unexplained weight loss.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.